Literature DB >> 15592474

Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells.

Anne L Ackerman1, Christoph Kyritsis, Robert Tampé, Peter Cresswell.   

Abstract

In dendritic cells (DCs), peptides derived from internalized particulate substrates are efficiently cross-presented by major histocompatibility complex (MHC) class I molecules. Exogenous soluble antigens are also presented by DCs but with substantially lower efficiency. Here we show that particulate and soluble antigens use different transport pathways. Particulate antigens have been shown to access peripheral endoplasmic reticulum (ER)-like phagosomes that are competent for cross-presentation, whereas we show here that soluble proteins that escape proteolysis enter the lumen of the ER. From there, they may be translocated into the cytosol by the pathway established for ER-associated degradation and their derived peptides may be transported back into the ER for binding by MHC class I molecules. MHC class I presentation involving the constitutive retrograde transport of soluble proteins to the ER by DCs may facilitate DC tolerance to components of their extracellular environment.

Mesh:

Substances:

Year:  2004        PMID: 15592474     DOI: 10.1038/ni1147

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  57 in total

1.  The pathway of cross-presentation is influenced by the particle size of phagocytosed antigen.

Authors:  Alexandra Mant; Fay Chinnery; Tim Elliott; Anthony P Williams
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 2.  The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors:  Richard A Hopkins; John E Connolly
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo.

Authors:  Rajakumar Mandraju; Sean Murray; James Forman; Chandrashekhar Pasare
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

4.  In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles.

Authors:  Young Jik Kwon; Edward James; Nilabh Shastri; Jean M J Fréchet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 5.  Viral evasion of the MHC class I antigen-processing machinery.

Authors:  Sandra Loch; Robert Tampé
Journal:  Pflugers Arch       Date:  2005-08-06       Impact factor: 3.657

6.  Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.

Authors:  Susan E Brophy; Lindsay L Jones; Phillip D Holler; David M Kranz
Journal:  Mol Immunol       Date:  2006-12-12       Impact factor: 4.407

7.  A vitellogenic-like carboxypeptidase expressed by human macrophages is localized in endoplasmic reticulum and membrane ruffles.

Authors:  James Harris; Nicole Schwinn; James A Mahoney; Hsi-Hsien Lin; Michael Shaw; Chris J Howard; Rosangela P da Silva; Siamon Gordon
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

8.  MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages.

Authors:  Edward W Eng; Adam Bettio; John Ibrahim; Rene E Harrison
Journal:  Mol Biol Cell       Date:  2007-04-18       Impact factor: 4.138

9.  Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses.

Authors:  Roberta Schiavo; Dolgor Baatar; Purevdorj Olkhanud; Fred E Indig; Nicholas Restifo; Dennis Taub; Arya Biragyn
Journal:  Blood       Date:  2006-03-02       Impact factor: 22.113

Review 10.  Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.

Authors:  Marianne Boes; Arie J Stoppelenburg; Fenna C M Sillé
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.